Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome

被引：0
|
作者：
Katayama, Takuji
Ueba, Hiroto
Tsuboi, Ken
Kubo, Norifumi
Yasu, Takanori
Kuroki, Masatoshi
Saito, Muneyasu
Kawakami, Masanobu
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A166 / A166
页数：1
相关论文
共 50 条
  • [1] Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome
    Katayama, Takuji
    Ueba, Hiroto
    Tsuboi, Ken
    Kubo, Norifumi
    Yasu, Takanori
    Kuroki, Masatoshi
    Saito, Muneyasu
    Momomura, Shin-ichi
    Kawakami, Masanobu
    AMERICAN HEART JOURNAL, 2007, 153 (05) : 762.e1 - 762.e7
  • [2] Pioglitazone reduces neointimal hyperplasia after coronary silent implantation in non-diabetic patients
    Katayama, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 43A - 43A
  • [3] Effect of cilostazol on neointimal hyperplasia after coronary artery stenting: Volumetric IVUS study
    Min, PK
    Jung, JH
    Park, S
    Kim, JY
    Choi, EY
    Ko, YG
    Shim, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 33A - 33A
  • [4] The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome
    Xu, Di
    Guo, Yan
    Wang, Hui
    Gu, Bing
    Liu, Genyan
    Zhou, Chuanwei
    Wu, Xin
    Wang, Junhong
    Cao, Kejiang
    ATHEROSCLEROSIS, 2012, 221 (02) : 416 - 421
  • [5] Restenosis risk factors after coronary stenting in metabolic syndrome patients
    Danilov, N. M.
    Gorgadze, T. T.
    Savchenko, A. P.
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (02): : 71 - 74
  • [6] Apoptosis inhibition reduces neointimal hyperplasia after coronary stenting in a porcine model of coronary artery restenosis
    Gyongyosi, M
    Sperker, W
    Lang, I
    Bonderman, D
    Wexberg, P
    Gottsauner-Wolf, M
    Glogar, D
    EUROPEAN HEART JOURNAL, 2001, 22 : 283 - 283
  • [7] Impact of gender on neointimal hyperplasia following coronary artery stenting
    Kaneda, H
    Ako, J
    Kataoka, T
    Takahashi, T
    Terashima, M
    Shimada, Y
    Waseda, K
    Miyazawa, A
    Sakurai, R
    Honda, Y
    Yock, PG
    Fitzgerald, PJ
    CIRCULATION, 2005, 112 (17) : U834 - U834
  • [8] Impact of gender on neointimal hyperplasia following coronary artery stenting
    Kaneda, Hideaki
    Ako, Junya
    Kataoka, Toru
    Takahashi, Takefumi
    Terashima, Mitsuyasu
    Waseda, Katsuhisa
    Miyazawa, Akiyoshi
    Hassan, Ali H. M.
    Honda, Yasuhiro
    Yock, Paul G.
    Fitzgerald, Peter J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04): : 491 - 493
  • [9] Pharmacodynamic effects of low-dose pioglitazone in nondiabetic patients with the metabolic syndrome
    Anh Vu
    Beitelshees, Amber
    Prigeon, Ronald
    Sidhom, Maha
    Bredbeck, Brooke
    Predhomme, Julie
    Kosmiski, Lisa
    Aquilante, Christina
    PHARMACOTHERAPY, 2013, 33 (10): : E276 - E277
  • [10] Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome
    Szapary, PO
    Bloedon, LT
    Samaha, FF
    Duffy, D
    Wolfe, ML
    Soffer, D
    Reilly, MP
    Chittams, J
    Rader, DJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) : 182 - 188
12345